European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Female sexuality after female cancer treatment: a clinical issue
D. Vaidakis1,*, T. Panoskaltsis2, N. Poulakaki3, A. Kouloura4, D. Kassanos3, G. Papadimitriou5, E. Salamalekis3
1 1st Gynecological Department, Anticancer Hospital, Saint Savvas Hospital, Athens
2 2nd University Department of Obstetrics and Gynecology, Athens Medical School, “Araiteio Hospital’’, Athens
3 3rd University Obstetrics and Gynecology Department, Athens Medical School, “Attikon Hospital’’, Athens
4 1st Department of Surgical Oncology, Anticancer Hospital, Saint Savvas Hospital, Athens
5 1st Department of Psychiatry, University of Athens, Medical School, Eginition Hospital, Athens (Greece)
Eur. J. Gynaecol. Oncol. 2014, 35(6), 635–640; https://doi.org/10.12892/ejgo24752014
Published: 10 December 2014
Purpose of investigation: The aim of the present study was to record how the treatment of female cancer may affect sexuality and interpersonal relations in the couple. Material and Methods: From September 2008 until February 2012, the authors prospectively studied 67 patients with breast cancer (Group A) and 43 with gynecological cancers (Group B). As control groups 33 patients with benign breast and 30 patients with benign gynecological lesions (group 0a and 0b respectively) were used. Sexuality and interpersonal relations were evaluated by a questionnaire. The authors also evaluated interpersonal relations focusing on sexual function at the time of diagnosis and a year after the initial treatment for cancer. Results: A significant reduction of the “sexual desire’’, “sexual Arousal’’, and “orgasm’’ dimension was found in both cancer groups, in contrast to the control group, revealing no significant change. The “sexual enjoyment’’ scale was significantly decreased in gynecological cancer group but not in breast cancer group. While the score on the “relationship quality’’ dimension significantly increased in both cancer groups. In all groups, there was a significantly positive correlation between sexual function and enjoyment; on the contrary, there was a significantly negative correlation between relationship quality and sexual function and enjoyment. Conclusion: Sexual dysfunctions is a clinical problem which should be evidenced at the beginning of therapy, from the oncologists in order to provide integrated treatment to their patients.
Female sexual disorders